AU Patent

AU2016254049A1 — Oxindole compounds and pharmaceutical compositions thereof

Assigned to MUSC Foundation for Research and Development · Expires 2017-11-02 · 9y expired

What this patent protects

Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degen…

USPTO Abstract

Provided herein are compounds of the formula (I) as well as pharmaceutically acceptable salts thereof, wherein the substituents are as those disclosed in the specification. These compounds, and the pharmaceutical compositions containing them, are useful for the treatment of degenerative diseases and disorders.

Drugs covered by this patent

Patent Metadata

Patent number
AU2016254049A1
Jurisdiction
AU
Classification
—
Expires
2017-11-02
Drug substance claim
No
Drug product claim
No
Assignee
MUSC Foundation for Research and Development
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.